Indefinite Delivery Contract 36E79722D0011
Award Date
3/21/22
Last Date to Order
3/20/26
Federal Agency
National Acquisition Center
Awardee
Sandoz Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...
The National Acquisition Center, a civilian federal agency, has awarded an indefinite delivery contract to Sandoz Inc., a global leader in generic pharmaceuticals, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The $766,987.10 contract has a base year plus four one-year option periods, and authorizes the ordering of products from Sandoz Inc.'s commercial catalogs to meet the medication needs of veterans, active duty military...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The IDC, valued at a ceiling of $236,745.90, is for the supply of TRIFLUOPERAZINE tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) healthcare networks. The contract has a base period of one year, with four one-year option periods, and...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. for the procurement of Dorzolamide HCL 22.3MG/Timolol Maleate 6.8MG/ML ophthalmic solution. The potential value of the contract is $11,919,384.20 over a one-year base period and four one-year option periods extending to May 2023. The originating pre-solicitation notice sought offers for an unrestricted procurement to supply the ophthalmic...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Greenstone LLC, a global healthcare company, to supply Prednisolone Acetate 1% Ophthalmic Suspension. The single-award contract has a ceiling value of $15,335,733.05 and a period of performance from May 1, 2022 to April 30, 2023, with four one-year option periods. The contract aims to provide an uninterrupted domestic supply of this corticosteroid eye medication to...
The federal government, through the National Acquisition Center (NAC) of the Department of Veterans Affairs (VA), has awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications. The $7,402,374.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of January 14, 2026. The contract aims to procure Amoxicillin/Clavulanate Tablets to meet the...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs National Acquisition Center to Sandoz Inc., provides a range of pharmaceutical products and services to support the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations. The contract, which has a total ceiling value of $683,208,960 and a period of performance through August 2028, utilizes the VA's prime vendor program to distribute products such as...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Bausch & Lomb Americas Inc. to procure PreserVision AREDS with Lutein and PreserVision AREDS 2 eye vitamins. The $59,545,977 contract has a one-year base period from August 1, 2022 to July 31, 2023, plus four one-year option periods. The contract items will be distributed through the VA's and Department of Defense's respective pharmaceutical prime vendor programs to serve the...
The federal contract IDV award SPE2D223D0007 is a single-award indefinite delivery contract granted to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a ceiling value of $17,621,453.20 and a period of performance running through February 14, 2028. This IDV contract aims to establish a national supply source for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottles, a commercial item, for purchase by the...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Golden State Medical Supply, Inc. to provide an uninterrupted supply of Dorzolamide 2% ophthalmic solution. With a potential value of $3.54 million and a base period of September 1, 2020 through August 31, 2021 plus four option years, the contract enables distribution of an estimated 170,000 bottles annually through the VA and DOD Pharmaceutical Prime Vendor programs to meet...